RETRACTABLE TECHNOLOGIES, INC. RECEIVES F.D.A. APPROVAL FOR VANISHPOINT® SAFETY IV CATHETER LITTLE ELM, TEXAS, October 11, 2005—Retractable Technologies, Inc. (AMEX:  RVP), a leading maker of safety needle devices, announced today it has received U.S. Food and Drug Administration (FDA) 510k approval to market its new VanishPoint® automated retraction intravenous (IV)